1114876-08-2 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-Methylazetidine-3-carboxylate hydrochloride is used as a key intermediate in the synthesis of various pharmaceutical compounds for its ability to contribute to the development of new drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, making it valuable in medicinal chemistry research.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Methyl 3-Methylazetidine-3-carboxylate hydrochloride is utilized as a building block for the design and synthesis of novel drug candidates. Its incorporation into molecular structures can enhance the pharmacological profiles of these candidates, potentially leading to more effective treatments for a range of diseases.
Used in Organic Synthesis:
Methyl 3-Methylazetidine-3-carboxylate hydrochloride serves as a versatile building block in organic synthesis, enabling the creation of complex organic molecules with potential applications in various chemical and pharmaceutical processes. Its reactivity and structural features make it a preferred choice for chemists working on the development of new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 1114876-08-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,4,8,7 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1114876-08:
(9*1)+(8*1)+(7*1)+(6*4)+(5*8)+(4*7)+(3*6)+(2*0)+(1*8)=142
142 % 10 = 2
So 1114876-08-2 is a valid CAS Registry Number.
1114876-08-2Relevant academic research and scientific papers
HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS
-
Page/Page column 148; 308, (2020/06/05)
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R1, R2, R4, R5, R6, R7, R8, R9, R10,Z, X1, X2, X3, L2, HET, n and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.
CYTOMEGALOVIRUS INHIBITOR COMPOUNDS
-
, (2013/10/22)
Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
NOVEL PYRIDINE COMPOUNDS
-
Page/Page column 172, (2008/06/13)
The present invention relates to certain novel pyridin compounds of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, and processes for their preparation, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
